BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15843388)

  • 1. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
    Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
    Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.
    Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NP; Estabrook RW
    Mutat Res; 1999 Feb; 439(2):287-300. PubMed ID: 10023085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
    Josephy PD; Evans DH; Parikh A; Guengerich FP
    Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
    Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
    Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
    Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
    Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5.
    Emmert B; Bünger J; Keuch K; Müller M; Emmert S; Hallier E; Westphal GA
    Toxicology; 2006 Nov; 228(1):66-76. PubMed ID: 16978761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation spectra analysis suggests that N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-induced lesions are subject to transcription-coupled repair in Escherichia coli.
    Iannone R; Inga A; Luque-Romero FL; Menichini P; Abbondandolo A; Abril N; Pueyo C; Fronza G
    Mol Carcinog; 1997 May; 19(1):39-45. PubMed ID: 9180927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
    Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
    Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cda GenoTox assay: a new and sensitive method for detection of environmental genotoxins, including nitroarenes and aromatic amines.
    Østergaard TG; Hansen LH; Binderup ML; Norman A; Sørensen SJ
    Mutat Res; 2007 Jul; 631(2):77-84. PubMed ID: 17532255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome b(5) coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium.
    Cooper MT; Porter TD
    Mutat Res; 2001 Dec; 484(1-2):61-8. PubMed ID: 11733072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase.
    Cooper MT; Porter TD
    Mutat Res; 2000 Nov; 454(1-2):45-52. PubMed ID: 11035158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of DNA repair by (A)BC excinuclease and Ogt alkyltransferase on the distribution of mutations induced by n-propyl-N-nitrosourea in Escherichia coli.
    Ferrezuelo F; Prieto-Alamo MJ; Jurado J; Pueyo C
    Environ Mol Mutagen; 1998; 31(1):82-91. PubMed ID: 9464319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
    Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
    Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system.
    Oda Y
    Mutat Res; 2004 Oct; 554(1-2):399-406. PubMed ID: 15450435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the drug efflux protein TolC in mutagenicity induced by MNNG or Trp-P-2.
    Takahashi E; Okamoto K; Arimoto S; Yamanaka H; Negishi T
    Mutat Res; 2006 Jun; 605(1-2):42-50. PubMed ID: 16713734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.